Repeated blood–brain barrier opening with an implantable ultrasound device

Dr. Roger Stupp and Dr. Adam M Sonabend present the findings of their paper, published in The Lancet Oncology on 2 May 2023:

Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

Read the full paper: https://www.thelancet.com/journals/la...

The results of this study are the basis for an ongoing phase 2 clinical trial investigating the efficacy of this approach in patients with recurrent glioblastoma.
For more information about this trial, go to https://clinicaltrials.gov/ct2/show/N...

This Video Abstract by The Lancet Oncology features:

Dr. Roger Stupp
Paul C. Bucy Professor of Neurological Surgery
Professor of Neurology and Medicine (Hematology/Oncology)
Chief, Division of Neuro-Oncology, Department of Neurology and
Co-Director, Malnati Brain Tumor Institute, Lurie Compr. Cancer Center
Northwestern University

Adam M Sonabend, MD, FAANS
Associate Professor of Neurological Surgery
Director of Translational Neuro-oncology
Department of Neurological Surgery
Feinberg School of Medicine
Northwestern University

Visit The Lancet Oncology at https://www.thelancet.com/journals/la...
Find out more at https://www.thelancet.com/?dgcid=yout...

* * *
Continue this conversation on social! Follow us today at…
  / thelancet   &   / thelancetoncol  
  / thelancetmedicaljournal  
  / the-lancet